Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Рынки
Скринер
Новости
О нас

PRA - ProAssurance Corporation Последние новости | Finranks

Home

PRA

P

ProAssurance Corporation (PRA)

NYQ – Цена в реальном времени. Валюта: USD

24.58

-0.14 (-0.57%)

При закрытии: Mar 27, 2026, 4:00 PM EDT

24.58

0.00 (0.00%)

После закрытия: Mar 27, 2026, 6:22 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

All You Need to Know About ProAssurance (PRA) Rating Upgrade to Strong Buy

All You Need to Know About ProAssurance (PRA) Rating Upgrade to Strong Buy

ProAssurance (PRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ProAssurance (PRA) Up 0.9% Since Last Earnings Report: Can It Continue?

ProAssurance (PRA) Up 0.9% Since Last Earnings Report: Can It Continue?

ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock?

Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA

Best Low-Beta Stocks to Own Right Away: AGRO, PRA, E & LQDA

Low-beta picks gain focus as Iran war fears stir volatility. AGRO, PRA, E and LQDA reflect resilience with momentum, liquidity and fundamentals.

What Makes ProAssurance (PRA) a Strong Momentum Stock: Buy Now?

What Makes ProAssurance (PRA) a Strong Momentum Stock: Buy Now?

Does ProAssurance (PRA) have what it takes to be a top stock pick for momentum investors? Let's find out.

ProAssurance Q4 Earnings Beat Estimates on Declining Expenses

ProAssurance Q4 Earnings Beat Estimates on Declining Expenses

PRA posts Q4 EPS of 82 cents, topping estimates as expenses fall and investment income rises despite lower premiums.

Compared to Estimates, ProAssurance (PRA) Q4 Earnings: A Look at Key Metrics

Compared to Estimates, ProAssurance (PRA) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for ProAssurance (PRA) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ProAssurance (PRA) Q4 Earnings and Revenues Surpass Estimates

ProAssurance (PRA) Q4 Earnings and Revenues Surpass Estimates

ProAssurance (PRA) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.36 per share a year ago.

Видео

No Data

There is no data to display

Пресс-релизы

ProAssurance Reports Results for Fourth Quarter and Full-Year 2025

ProAssurance Reports Results for Fourth Quarter and Full-Year 2025

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $33.4 million, or $0.64 per diluted share, and operating income(1) of $42.4 million, or $0.82 per diluted share, for the three months ended December 31, 2025. For the year ended December 31, 2025, net income was $50.9 million, or $0.99 per diluted share, and operating income was $83.9 million, or $.

ProAssurance Reports Results for Third Quarter 2025

ProAssurance Reports Results for Third Quarter 2025

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $1.4 million, or $0.03 per diluted share, and operating income(1) of $7.9 million, or $0.15 per diluted share, for the three months ended September 30, 2025. For the nine months ended September 30, 2025, net income was $17.5 million, or $0.34 per diluted share, and operating income was $41.5 millio.

ProAssurance Reports Results for Second Quarter 2025

ProAssurance Reports Results for Second Quarter 2025

BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $21.9 million, or $0.42 per diluted share, and operating income(1) of $26.8 million, or $0.52 per diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2025, net income was $16.1 million, or $0.31 per diluted share, and operating income was $33.6 million, or $0.